The sales are small and tied to option exercises, not a bearish signal. Monitor for any insider buying or material news (e.g., clinical data readouts) that could shift sentiment. No immediate trading catalyst from this cluster alone.
Price Chart
Executive Summary
Two senior executives at Enliven Therapeutics (CMO and CFO) sold a combined $424K in open-market sales on October 19, 2026, following derivative exercises. The sales are modest relative to the company's market cap and appear tied to option exercises and tax planning, not a material negative signal. The cluster is routine in size and lacks the urgency of a conviction-based sell-off.
Key Financial Metrics
Key Facts
- CMO Helen Louise Collins sold 5,000 shares at $38.47 for $192K after exercising options at $0 and $2.48 per share.
- CFO Benjamin Hohl sold 6,000 shares at $38.48 for $232K.
- Total insider sales of $424K represent a trivial fraction of Enliven's market cap (likely <0.2%).
- Both sales occurred on the same day and follow derivative exercises, consistent with tax withholding or routine diversification.
Financial Impact
Total insider sales of $424K, immaterial relative to market cap.
Risk Factors
- Insiders may continue selling if stock appreciates further, but current volume is routine.
- No insider buying to offset sales could indicate lack of conviction at current levels.
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-ELVN-1792619648176 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 21, 2026 5d ago | Insider Cluster | $41.93 | awaiting T+5 | — | $41.49 (−1.05%) |
Oct 19, 2026 7d ago | 144 | $41.25 | awaiting T+5 | — | $41.49 (+0.58%) |
Oct 16, 2026 10d ago | 3 | $38.70 $41.49 | ▲ +7.21% | ▲ +7.35% | $41.49 (+7.21%) |
Oct 14, 2026 12d ago | 8-K | $39.33 $41.93 | ▲ +6.61% | ▲ +7.63% | $41.49 (+5.49%) |
Sep 21, 2026 5w ago | Insider Cluster | $48.19 $46.51 | ▼ −3.49% | ▼ −2.30% | $41.49 (−13.90%) |
Sep 4, 2026 7w ago | 144 | $59.32 $54.43 | ▼ −8.24% | ▼ −7.03% | $41.49 (−30.06%) |
Aug 19, 2026 9w ago | Insider Cluster | $58.97 $60.50 | ▲ +2.59% | ▲ +1.48% | $41.49 (−29.64%) |
Aug 9, 2026 11w ago | Institutional Cluster | $59.42 $59.54 | ▲ +0.19% | ▲ +0.24% | $41.49 (−30.18%) |
Jul 21, 2026 13w ago | Insider Cluster | $52.85 $52.97 | ▲ +0.23% | ▲ +2.63% | $41.49 (−21.49%) |
Jun 22, 2026 18w ago | 144 | $48.60 $50.85 | ▲ +4.63% | ▲ +3.62% | $41.49 (−14.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers